NASDAQ
HIT
Last Price
US $1.01
KEY FIGURES
MKT CAP
$56.0M
EPS
TTM
$-0.01
PEG
TTM
-
P/E
TTM
N/M
P/S
TTM
1.68x
YIELD
0.00%
GROWTH
Revenue Y/Y
-
(FY vs FY)
EBITDA Y/Y
Cash Flow (DCF)
Fair Value
Market $1.01
—
Default assumptions
EBITDA Multiple
Fair Value
Market $1.01
-52.48%
Default assumptions
Valuation
Financial
Performance
Financial stability - Cash flow debt coverage.
Health In Tech, Inc. cash flow to debt ratio of 2.24K% indicates that the company generates enough cash to cover a substantial portion of its debt. This level indicates very strong financial health.
Financial risk - Healthy cash flow growth.
Health In Tech, Inc.'s free cash flow has decreased -104.40% from $1.28M last year to $-56.11K, signaling decreasing performance
Financial stability - Healthy debt to equity ratio.
Health In Tech, Inc.'s debt to equity ratio is 0.01, which means that the company's assets are healthy financed, signaling financial stability. READ MORE: A ratio under 0.60 means the company finances its assets with own equity, signaling financial stability and good management.
Financial stability - Healthy debt to equity ratio development.
Health In Tech, Inc.'s debt has decreased relative to shareholder equity from 0.02 last year to 0.01 today, signaling strengthened financials
Financial stability - Net debt/EBITDA.
Health In Tech, Inc. has a net debt to EBITDA ratio of 0.00x, which is below the 3.00x threshold, indicating healthy leverage and financial stability
Financial stability - ICR.
Health In Tech, Inc. earns at least as much interest as it pays. Interest obligations are fully covered.
Financial risk - Profit margin growth.
Health In Tech, Inc.'s profit margin has decreased (-168.92%) in the last year from 3.44% to -2.37%, signaling decreasing performance
Financial stability - Short term assets vs short term liabilities.
Health In Tech, Inc.'s short-term assets of $16.16M exceed its short-term liabilities of $5.16M
Decreasing performance - ROA.
Health In Tech, Inc.'s return on assets of -2.79% is lower than the 5.00% threshold, indicating inefficient asset utilization
Decreasing performance - Absolute return on equity.
Health In Tech, Inc.'s return on equity of -4.47%, is lower than 15.00%, indicating bad performance
Increasing performance - Earnings quality.
Health In Tech, Inc.'s operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation
Increasing performance - Earnings stability.
Health In Tech, Inc. had positive net income in 4.00 out of 5 years, indicating stable and consistent earnings
Decreasing performance - Free cash flow.
Health In Tech, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it
Decreasing performance - FCF yield.
Health In Tech, Inc. has negative free cash flow, indicating cash burn
Increasing performance - Healthy earnings growth.
Health In Tech, Inc.'s yearly earnings has increased 90.74% since last year from $670.48K to $1.28M, signaling increasing performance
Increasing performance - Healthy revenue growth.
Health In Tech, Inc.'s yearly revenue has increased 70.99% since last year from $19.49M to $33.33M, signaling increasing performance
Decreasing performance - ROIC.
ROIC -3.78% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
Increasing performance - 3-year revenue CAGR.
Health In Tech, Inc.'s 3-year revenue CAGR of 79.42% is positive, indicating growing revenue over the past 3 years
Increasing performance - Revenue consistency.
Health In Tech, Inc. had revenue growth in 3.00 out of 5 years, indicating consistent revenue performance
Increasing performance - ROE consistency.
Health In Tech, Inc. had positive ROE in 4.00 out of 5 years, indicating consistent and reliable returns on equity
Overvalued - DCF valuation.
Health In Tech, Inc. has insufficient data to evaluate this check.
Overvalued - Earnings yield.
Health In Tech, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Overvalued - EBITDA valuation.
Health In Tech, Inc. is overvalued relative to its fair value price of 0.48 based on EBITDA multiple model
Overvalued - EV/EBITDA.
Health In Tech, Inc. has an EV/EBITDA ratio of 511.87x, which exceeds the 20.00x threshold, indicating the stock may be overvalued relative to its operating earnings
Overvalued - PEG ratio value.
Health In Tech, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Undervalued - P/B ratio.
Health In Tech, Inc. has a price-to-book ratio of 2.76x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Undervalued - P/S ratio.
Health In Tech, Inc. has a price-to-sales ratio of 1.64x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
-4.47%
Return on equity
ROIC: -3.78%
Valuation History
-54.5X
Price to Earnings
EV/EBITDA: 511.9X
Cash flow
Profit margin
-
(FY vs FY)
Cash flow Y/Y
-
(FY vs FY)
EARNINGS FV (GRAHAM)
Fair Value
Market $1.01
—
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.